Process View
Any process that increases the rate, frequency, or extent of the series of events that restore integrity to a damaged tissue, following an injury.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "positive regulation of wound healing"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| RHOA | ras homolog gene family, member A | 0.991 | Fly | |
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.893 | ||
| SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.866 | ||
| VEGFA | vascular endothelial growth factor A | 0.843 | Human | |
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.839 | ||
| IQGAP1 | IQ motif containing GTPase activating protein 1 | 0.797 | ||
| CALM1 | calmodulin 1 (phosphorylase kinase, delta) | 0.778 | ||
| ARHGAP1 | Rho GTPase activating protein 1 | 0.738 | ||
| MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.647 | ||
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.611 | Fly | |
| NCF1 | neutrophil cytosolic factor 1 | 0.608 | ||
| MAPK1 | mitogen-activated protein kinase 1 | 0.568 | Fly | |
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.560 | ||
| NCOA1 | nuclear receptor coactivator 1 | 0.512 | ||
| NRP1 | neuropilin 1 | 0.469 | ||
| PLAUR | plasminogen activator, urokinase receptor | 0.416 | ||
| NCF2 | neutrophil cytosolic factor 2 | 0.401 | ||
| RAC1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) | 0.340 | Fly | |
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.336 | Fly | |
| ARHGAP10 | Rho GTPase activating protein 10 | 0.310 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.268 | Human | |
| PLAU | plasminogen activator, urokinase | 0.242 | Human | |
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.241 | ||
| NCF4 | neutrophil cytosolic factor 4, 40kDa | 0.226 | ||
| MAGI2 | membrane associated guanylate kinase, WW and PDZ domain containing 2 | 0.202 | ||
| PTPN13 | protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase) | 0.162 | ||
| S100A4 | S100 calcium binding protein A4 | 0.154 | ||
| EGFR | epidermal growth factor receptor | 0.153 | Fly | |
| FGA | fibrinogen alpha chain | 0.139 | ||
| CDC42 | cell division cycle 42 (GTP binding protein, 25kDa) | 0.134 | Fly | |
| TGFB1 | transforming growth factor, beta 1 | 0.127 | ||
| RAF1 | v-raf-1 murine leukemia viral oncogene homolog 1 | 0.108 | ||
| RALBP1 | ralA binding protein 1 | 0.102 | ||
| ARHGDIB | Rho GDP dissociation inhibitor (GDI) beta | 0.099 | ||
| MAPK14 | mitogen-activated protein kinase 14 | 0.093 | ||
| MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.090 | ||
| ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.087 | ||
| RALA | v-ral simian leukemia viral oncogene homolog A (ras related) | 0.086 | Human | |
| MPDZ | multiple PDZ domain protein | 0.086 | ||
| PLG | plasminogen | 0.083 | ||
| MAP2K1 | mitogen-activated protein kinase kinase 1 | 0.083 | ||
| PLCG1 | phospholipase C, gamma 1 | 0.082 | ||
| LTA | lymphotoxin alpha (TNF superfamily, member 1) | 0.076 | ||
| PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.075 | Mouse | |
| EMP3 | epithelial membrane protein 3 | 0.075 | ||
| GNAI2 | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 | 0.074 | ||
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.073 | ||
| PLAT | plasminogen activator, tissue | 0.070 | Human | |
| SERPINC1 | serpin peptidase inhibitor, clade C (antithrombin), member 1 | 0.066 | ||
| MAGI3 | membrane associated guanylate kinase, WW and PDZ domain containing 3 | 0.063 | ||
| PDGFC | platelet derived growth factor C | 0.062 | ||
| CYBA | cytochrome b-245, alpha polypeptide | 0.061 | ||
| ALB | albumin | 0.061 | ||
| KEAP1 | kelch-like ECH-associated protein 1 | 0.059 | ||
| MSN | moesin | 0.058 | ||
| PTPRB | protein tyrosine phosphatase, receptor type, B | 0.055 | ||
| FGB | fibrinogen beta chain | 0.051 | ||
| APOH | apolipoprotein H (beta-2-glycoprotein I) | 0.051 | ||
| ANKS1B | ankyrin repeat and sterile alpha motif domain containing 1B | 0.050 | ||
| ABI1 | abl-interactor 1 | 0.049 | ||
| GRIN2B | glutamate receptor, ionotropic, N-methyl D-aspartate 2B | 0.048 | ||
| RALB | v-ral simian leukemia viral oncogene homolog B (ras related; GTP binding protein) | 0.046 | Human | |
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.045 | Rat | |
| PTEN | phosphatase and tensin homolog | 0.044 | ||
| RPS6KA2 | ribosomal protein S6 kinase, 90kDa, polypeptide 2 | 0.042 | ||
| TTN | titin | 0.042 | ||
| EZR | ezrin | 0.041 | ||
| ARHGEF12 | Rho guanine nucleotide exchange factor (GEF) 12 | 0.041 | ||
| PGF | placental growth factor | 0.040 | Human | |
| PEA15 | phosphoprotein enriched in astrocytes 15 | 0.040 | ||
| C1S | complement component 1, s subcomponent | 0.040 | ||
| PRKCD | protein kinase C, delta | 0.039 | ||
| ENG | endoglin | 0.038 | ||
| ILK | integrin-linked kinase | 0.038 | ||
| PRKCA | protein kinase C, alpha | 0.035 | Human | |
| CD320 | CD320 molecule | 0.034 | ||
| DLG4 | discs, large homolog 4 (Drosophila) | 0.034 | ||
| THBS1 | thrombospondin 1 | 0.032 | ||
| COL1A1 | collagen, type I, alpha 1 | 0.032 | ||
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.032 | ||
| CACNA1C | calcium channel, voltage-dependent, L type, alpha 1C subunit | 0.031 | ||
| COL4A1 | collagen, type IV, alpha 1 | 0.031 | ||
| F3 | coagulation factor III (thromboplastin, tissue factor) | 0.029 | ||
| LY96 | lymphocyte antigen 96 | 0.029 | ||
| ARHGDIA | Rho GDP dissociation inhibitor (GDI) alpha | 0.029 | ||
| ABL2 | v-abl Abelson murine leukemia viral oncogene homolog 2 | 0.029 | ||
| DAB2 | disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) | 0.028 | ||
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.028 | Human | |
| YWHAZ | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide | 0.027 | ||
| NCOA3 | nuclear receptor coactivator 3 | 0.027 | ||
| TIMP1 | TIMP metallopeptidase inhibitor 1 | 0.027 | ||
| ARHGAP26 | Rho GTPase activating protein 26 | 0.027 | ||
| RALGDS | ral guanine nucleotide dissociation stimulator | 0.027 | ||
| SMAD2 | SMAD family member 2 | 0.026 | ||
| TICAM2 | toll-like receptor adaptor molecule 2 | 0.026 | ||
| MAFG | v-maf musculoaponeurotic fibrosarcoma oncogene homolog G (avian) | 0.026 | ||
| C1R | complement component 1, r subcomponent | 0.025 | ||
| ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.025 | ||
| BACH1 | BTB and CNC homology 1, basic leucine zipper transcription factor 1 | 0.024 | ||
| KNG1 | kininogen 1 | 0.024 | ||
| TNFRSF12A | tumor necrosis factor receptor superfamily, member 12A | 0.023 | ||
| DUSP1 | dual specificity phosphatase 1 | 0.023 | ||
| RHOC | ras homolog gene family, member C | 0.022 | Fly | |
| PTPRC | protein tyrosine phosphatase, receptor type, C | 0.022 | ||
| SLC9A3R1 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 | 0.021 | ||
| S100A2 | S100 calcium binding protein A2 | 0.021 | ||
| COL5A1 | collagen, type V, alpha 1 | 0.021 | ||
| GAB1 | GRB2-associated binding protein 1 | 0.021 | ||
| TSG101 | tumor susceptibility gene 101 | 0.021 | ||
| TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.020 | ||
| VTN | vitronectin | 0.020 | ||
| BRAF | v-raf murine sarcoma viral oncogene homolog B1 | 0.020 | ||
| HDAC6 | histone deacetylase 6 | 0.019 | ||
| TGFB3 | transforming growth factor, beta 3 | 0.019 | ||
| TIRAP | toll-interleukin 1 receptor (TIR) domain containing adaptor protein | 0.019 | ||
| TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.019 | ||
| PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.019 | ||
| TGFBR1 | transforming growth factor, beta receptor 1 | 0.018 | ||
| SERPINF2 | serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2 | 0.018 | ||
| CAPNS1 | calpain, small subunit 1 | 0.018 | ||
| DLG2 | discs, large homolog 2 (Drosophila) | 0.018 | ||
| TRIM9 | tripartite motif containing 9 | 0.018 | ||
| AXL | AXL receptor tyrosine kinase | 0.018 | ||
| GRIN2C | glutamate receptor, ionotropic, N-methyl D-aspartate 2C | 0.018 | ||
| LPA | lipoprotein, Lp(a) | 0.018 | Human | |
| PLEKHA1 | pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1 | 0.017 | ||
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.017 | ||
| CD151 | CD151 molecule (Raph blood group) | 0.017 | ||
| DLG3 | discs, large homolog 3 (Drosophila) | 0.017 | ||
| KCNA4 | potassium voltage-gated channel, shaker-related subfamily, member 4 | 0.017 | ||
| GAB2 | GRB2-associated binding protein 2 | 0.017 | ||
| KCNA1 | potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia) | 0.017 | ||
| PHLDA1 | pleckstrin homology-like domain, family A, member 1 | 0.017 | ||
| BCL6 | B-cell CLL/lymphoma 6 | 0.017 | ||
| AKNA | AT-hook transcription factor | 0.016 | ||
| FKBP8 | FK506 binding protein 8, 38kDa | 0.016 | ||
| C8B | complement component 8, beta polypeptide | 0.016 | ||
| PEBP1 | phosphatidylethanolamine binding protein 1 | 0.016 | ||
| CSRP3 | cysteine and glycine-rich protein 3 (cardiac LIM protein) | 0.016 | ||
| ROD1 | ROD1 regulator of differentiation 1 (S. pombe) | 0.016 | ||
| MAPK3 | mitogen-activated protein kinase 3 | 0.016 | Fly | |
| TGFBI | transforming growth factor, beta-induced, 68kDa | 0.016 | ||
| CREBBP | CREB binding protein | 0.016 | ||
| ITIH2 | inter-alpha (globulin) inhibitor H2 | 0.015 | ||
| SOS1 | son of sevenless homolog 1 (Drosophila) | 0.015 | ||
| COL1A2 | collagen, type I, alpha 2 | 0.015 | ||
| ORM1 | orosomucoid 1 | 0.015 | ||
| PIK3R2 | phosphoinositide-3-kinase, regulatory subunit 2 (beta) | 0.015 | ||
| PAWR | PRKC, apoptosis, WT1, regulator | 0.015 | ||
| RANBP9 | RAN binding protein 9 | 0.015 | ||
| EFTUD2 | elongation factor Tu GTP binding domain containing 2 | 0.014 | ||
| F13A1 | coagulation factor XIII, A1 polypeptide | 0.014 | ||
| INPP5A | inositol polyphosphate-5-phosphatase, 40kDa | 0.014 | ||
| DDR2 | discoidin domain receptor tyrosine kinase 2 | 0.014 | ||
| F10 | coagulation factor X | 0.014 | Human | |
| PRODH2 | proline dehydrogenase (oxidase) 2 | 0.013 | ||
| HGF | hepatocyte growth factor (hepapoietin A; scatter factor) | 0.013 | Human | |
| FYN | FYN oncogene related to SRC, FGR, YES | 0.013 | ||
| BTK | Bruton agammaglobulinemia tyrosine kinase | 0.013 | ||
| PLD1 | phospholipase D1, phosphatidylcholine-specific | 0.013 | ||
| HSPG2 | heparan sulfate proteoglycan 2 | 0.013 | ||
| BAD | BCL2-associated agonist of cell death | 0.013 | ||
| ARHGEF11 | Rho guanine nucleotide exchange factor (GEF) 11 | 0.013 | ||
| DUSP3 | dual specificity phosphatase 3 | 0.013 | ||
| ENPP5 | ectonucleotide pyrophosphatase/phosphodiesterase 5 (putative) | 0.013 | ||
| RHOU | ras homolog gene family, member U | 0.012 | ||
| PROCR | protein C receptor, endothelial | 0.012 | ||
| AHSG | alpha-2-HS-glycoprotein | 0.012 | ||
| OBSCN | obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF | 0.012 | ||
| PAK2 | p21 protein (Cdc42/Rac)-activated kinase 2 | 0.012 | ||
| TAX1BP3 | Tax1 (human T-cell leukemia virus type I) binding protein 3 | 0.012 | ||
| HCLS1 | hematopoietic cell-specific Lyn substrate 1 | 0.012 | ||
| SPARC | secreted protein, acidic, cysteine-rich (osteonectin) | 0.012 | ||
| SH2B3 | SH2B adaptor protein 3 | 0.012 | ||
| CD81 | CD81 molecule | 0.012 | ||
| SRPX | sushi-repeat containing protein, X-linked | 0.012 | ||
| PLXNB1 | plexin B1 | 0.012 | ||
| TAT | tyrosine aminotransferase | 0.012 | ||
| CTTN | cortactin | 0.012 | ||
| CYP4A11 | cytochrome P450, family 4, subfamily A, polypeptide 11 | 0.012 | ||
| ATF2 | activating transcription factor 2 | 0.012 | ||
| FLT4 | fms-related tyrosine kinase 4 | 0.011 | ||
| IGF1 | insulin-like growth factor 1 (somatomedin C) | 0.011 | ||
| COL2A1 | collagen, type II, alpha 1 | 0.011 | ||
| TSPAN4 | tetraspanin 4 | 0.011 | ||
| PDE4DIP | phosphodiesterase 4D interacting protein | 0.011 | ||
| ARRDC3 | arrestin domain containing 3 | 0.011 | ||
| SNTA1 | syntrophin, alpha 1 (dystrophin-associated protein A1, 59kDa, acidic component) | 0.011 | ||
| EIF2AK3 | eukaryotic translation initiation factor 2-alpha kinase 3 | 0.011 | ||
| USP33 | ubiquitin specific peptidase 33 | 0.011 | ||
| GRIN2A | glutamate receptor, ionotropic, N-methyl D-aspartate 2A | 0.011 | ||
| ECSIT | ECSIT homolog (Drosophila) | 0.011 | ||
| PTHLH | parathyroid hormone-like hormone | 0.011 | ||
| UBE2R2 | ubiquitin-conjugating enzyme E2R 2 | 0.011 | ||
| STC1 | stanniocalcin 1 | 0.011 | ||
| PEBP4 | phosphatidylethanolamine-binding protein 4 | 0.011 | ||
| TNC | tenascin C | 0.011 | ||
| COL3A1 | collagen, type III, alpha 1 | 0.011 | ||
| CHRD | chordin | 0.011 | ||
| SMAD7 | SMAD family member 7 | 0.011 | ||
| NRG1 | neuregulin 1 | 0.011 | ||
| HCFC1R1 | host cell factor C1 regulator 1 (XPO1 dependent) | 0.011 | ||
| CAV2 | caveolin 2 | 0.010 | ||
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.010 | ||
| CTNND1 | catenin (cadherin-associated protein), delta 1 | 0.010 | ||
| APOC3 | apolipoprotein C-III | 0.010 | ||
| MMP9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | 0.010 | ||
| SERPIND1 | serpin peptidase inhibitor, clade D (heparin cofactor), member 1 | 0.010 | ||
| VEGFC | vascular endothelial growth factor C | 0.010 | Human | |
| AMT | aminomethyltransferase | 0.010 | ||
| F2 | coagulation factor II (thrombin) | 0.010 |